Position in TEVA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,023,814
New position
Shares Held
443,442
first reported quarter
Ownership
0.038%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#123
of 671 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Nykredit A/S holds $44,861,153 across 22 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (33.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
443,442 | $15,023,814 | |
| 2 | ZTS |
Zoetis Inc.
|
139,745 | $10,042,075 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
16,970 | $9,194,855 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
37,372 | $6,298,676 | |
| 5 | RDY |
Dr Reddys Laboratories Ltd
|
137,993 | $1,999,518 | |
| 6 | VTRS |
Viatris Inc
|
27,143 | $431,030 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
14,474 | $356,205 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
7,509 | $308,094 |
All Filings in TEVA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,023,814 | 443,442 | Shares | Defined | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||